Operator

Good day, and thank you for standing by. Welcome to ALS Limited FY '26 Results Briefing. [Operator Instructions]

Please be advised that today's conference is being recorded. I would now like to turn the call over to your first speaker today, Mr. Malcolm Deane, CEO and Managing Director. Thank you. Please go ahead.

Malcolm Deane
CEO, MD & Director

Thanks, Desmond, and good morning, and thank you, everyone, for joining us today. It's been a very strong year for ALS, and we've delivered record results, reflecting our ability to achieve strong growth while staying disciplined on margin performance, cash generation and capital allocation. As always, I'm joined by Stuart Hutton, our Chief Financial Officer. We'll speak for around 30 minutes, and then we will open for questions.

Four years ago, we set ourselves ambitious fiscal year '27 targets. I'm pleased to report that we have achieved these targets 12 months early while refining our strategy and focus for the future. What's most pleasing is that we achieved the fiscal year '27 plan primarily through strong organic growth.

Fiscal year '26 revenue was $3.32 billion, up 10.7%, with strong organic growth of 8.4% at the top end of our guided range, reflecting the breadth of our global operations. Underlying EBIT of $599 million, up 19.3% with EBIT margin accelerating by